The useful question with this Norwood scale walk-through is not whether one photo looks better or worse. It is whether the pattern, timing, measurements, and treatment trade-offs point to a decision that will still make sense six months from now.
Last year a friend of mine, Tom, a 34-year-old software developer in Austin, texted me two bathroom-mirror photos taken eleven months apart. Same phone, same bathroom. But the lighting was completely different, the angles were off by maybe 20 degrees, and in the second shot he’d towel-dried his hair while in the first it was slicked wet. “Look, it’s definitely worse, right?” he asked. Honestly, I couldn’t tell. Neither could his dermatologist. Those eleven months of visual data were basically useless, and that’s a frustration I hear constantly from guys who are trying to track what’s happening on their scalp.
This article is about the boring infrastructure behind meaningful hair loss documentation: the classification system that still anchors clinical practice, the biology that determines what you’re actually watching change, and the practical moves that make your photos worth something over time.
Why the Norwood Scale Has Survived for 50 Years
Pattern hair loss has been formally studied since James Hamilton’s 1951 paper in the Annals of the New York Academy of Sciences. Hamilton noticed that men castrated before puberty never developed the classic recession and crown thinning of androgenetic alopecia, which nailed down the hormonal connection. His original classification, though, was limited to just three stages.
O’Tar Norwood’s 1975 paper in the Southern Medical Journal expanded that into a seven-stage system with variant subtypes, including the Type A variant where thinning marches straight backward from the front rather than following the more common bitemporal-plus-vertex pattern. That combined Hamilton-Norwood scale has now been the dominant framework in dermatology for over 70 years.
The reason it lasted is almost disappointingly simple. It’s easy to use. A dermatologist, a hair transplant surgeon, and a patient looking at photos online can all land on roughly the same stage number without specialized equipment. The basic and specific (BASP) classification proposed in 2007 tried to capture more granularity, but that added complexity never displaced the Norwood system in routine clinical work. In a field where the patient needs to communicate meaningfully with the doctor, “I think I’m a Norwood 3 vertex” turns out to be more useful than a more precise but less intuitive code.
See also: Green Tech Innovations: How Technology Is Fighting Climate Change
The Biology You’re Actually Photographing
When you take a photo of your hairline every few months, what you’re really documenting is follicular miniaturization, and behind that process sits one molecule: dihydrotestosterone (DHT).
DHT is produced from testosterone by the enzyme 5-alpha reductase. In genetically susceptible follicles, DHT binds to the androgen receptor in the dermal papilla and starts a slow cascade across successive hair cycles. The anagen (growth) phase shortens. The telogen (resting) phase stretches out. The dermal papilla physically shrinks. Thick terminal hairs become progressively thinner, shorter, and eventually turn into wispy, nonpigmented vellus hairs that contribute almost nothing to visible coverage.
The genetics here are polygenic. The androgen receptor gene on the X chromosome gets the most attention, which is why people look at the mother’s father as a predictor. But autosomal loci from the paternal side contribute meaningfully too. Family history is a rough compass, not a map.
Two drugs exploit this biology directly. Finasteride blocks the type II isoform of 5-alpha reductase, lowering scalp DHT. Dutasteride blocks both type I and type II isoforms, lowering DHT more aggressively, with correspondingly larger effects on hair density in head-to-head trials (Olsen et al., 2006, JAAD).
What a Proper Dermatology Evaluation Looks Like
The American Academy of Dermatology’s clinical guidelines for hair loss go well beyond eyeballing the hairline. A complete workup typically includes patient history, family history, scalp examination, trichoscopy (dermoscopy of the scalp), and selective lab work.
History matters a lot. Timeline of loss, whether it’s episodic or progressive, medications, recent illness, dietary changes. Pattern distribution helps separate androgenetic alopecia from telogen effluvium, alopecia areata, scarring alopecias, and traction effects.
Trichoscopy adds a layer the naked eye can’t reach. In androgenetic alopecia, you see hair shaft diameter variability (caliber variability of 20% or more), yellow dots where follicular ostia have emptied out, and decreased follicular unit density in affected areas while the occipital donor zone stays intact.
Lab testing is selective, not routine. Ferritin, thyroid stimulating hormone, vitamin D, and CBC make sense when telogen effluvium is on the differential or when someone presents with diffuse thinning. The AAD does not recommend routine androgen panels for men with classic pattern loss. The diagnosis is clinical.
And then there’s standardized photography, which is where this all circles back. Front, top, sides, and back views taken at consistent distance and lighting, with the head in a reproducible position. That’s what actually lets you compare meaningfully across months. Tom’s bathroom selfies failed on every single one of those criteria.
Patients who want a more detailed reference for staging can review this Norwood scale walk-through, which provides photographic examples and additional clinical context for each stage.
Treatments: What Works, in Order of Evidence Strength
Treatment is most effective when you start before significant follicular loss has occurred. Waiting until you’re clearly a Norwood 5 to begin medical therapy is like starting to save for retirement at 55. Not pointless, but you’ve lost a lot of compounding time.
Oral finasteride 1 mg daily has the deepest evidence base. The original five-year randomized trial published in JAAD in 2002 showed sustained improvements in hair count and patient self-assessment versus placebo. Sexual side effects affect a small percentage of users in randomized data and are generally reversible on discontinuation.
Topical minoxidil 5% applied twice daily is FDA-approved over the counter. The mechanism isn’t fully understood but involves potassium channel opening, vasodilation, and a direct follicular effect that prolongs anagen. Response typically becomes visible at three to six months. Foam and solution are clinically equivalent; foam causes less scalp irritation in some patients.
Low-dose oral minoxidil (0.25 to 5 mg daily) is increasingly prescribed off-label following Vañó-Galván et al.’s 2021 multicenter study of 1,404 patients in JAAD, which showed the side-effect profile at low doses is more manageable than originally feared. Periorbital edema and hypertrichosis are the most commonly reported issues.
Dutasteride is approved for benign prostatic hypertrophy and used off-label for hair loss, producing larger DHT reductions and larger hair density improvements than finasteride in head-to-head data.
PRP and microneedling have a modest evidence base as adjuncts. JAMA Dermatology has published several smaller randomized trials with positive but variable findings (Gentile & Garcovich, 2020). Reasonable additions, not substitutes.
Hair transplantation (FUE or FUT) is the only intervention that physically moves follicles from the donor zone to recipient areas. Most appropriate when the loss pattern has stabilized, donor capacity is adequate, and expectations are realistic.
What It Costs (and What Insurance Won’t Cover)
Generic oral finasteride runs $10 to $25 per month at US pharmacies with discount cards, sometimes $5 to $15 through direct-to-consumer telehealth. Branded Propecia still costs $70 to $90 monthly with no clinical advantage over the generic. That’s one of the clearest examples of paying for a label in all of medicine.
Generic topical minoxidil runs $10 to $30 per month. Low-dose oral minoxidil is often under $15 per month in generic form, though the prescribing visit may cost $50 to $150 through telehealth.
FUE hair transplantation in the US typically costs $4 to $10 per graft. A typical 2,500 to 3,500 graft case puts you at $10,000 to $35,000. In Turkey, the same graft count runs $2,000 to $5,000, a difference driven largely by labor costs and clinic overhead rather than necessarily by quality.
PRP runs $500 to $1,500 per session, with most protocols calling for three to four sessions in the first year plus maintenance. First-year PRP costs can easily exceed what you’d spend on a full year of combination medical therapy.
Insurance almost universally classifies pattern hair loss as cosmetic. HSA and FSA accounts may cover prescribed medications and physician visits but generally not surgical procedures.
Lifestyle Factors: What the Data Actually Says vs. What Reddit Says
Pattern hair loss is genetically determined. Full stop. But several lifestyle factors influence the tempo of shedding and overall hair quality.
Smoking accelerates hair loss through microvascular damage to the dermal papilla, oxidative stress, and effects on circulating androgens. Cross-sectional studies show higher androgenetic alopecia rates in smokers versus nonsmokers in matched populations.
Iron deficiency (serum ferritin below 30 ng/mL in women, below 50 ng/mL when hair loss is a concern) contributes to shedding through telogen effluvium mechanisms. Repleting iron in deficient patients reduces shedding. Supplementing iron in iron-replete patients does nothing for density.
Severe acute stress can trigger telogen effluvium beginning two to three months after the event. It typically resolves within six to nine months once the stressor passes, though it may unmask underlying pattern loss that was previously subclinical.
Anabolic steroid use accelerates pattern hair loss in genetically susceptible men via supraphysiologic androgen exposure. The effects may not be fully reversible after discontinuation.
Diet quality matters at the margin. Severe caloric restriction, very low protein intake, and rapid weight loss all reliably produce telogen effluvium. Modest dietary improvements don’t produce visible hair benefits beyond correcting specific deficiencies. That supplement stack you’re considering is almost certainly not going to outperform finasteride.
When to See a Dermatologist In Person
Self-management is reasonable in many situations. But several scenarios call for an in-person evaluation rather than telehealth or AI screening tools.
Sudden diffuse shedding that started in the last six months suggests telogen effluvium, which needs a workup for precipitating causes, not pattern hair loss medication. Patchy loss with smooth, well-circumscribed bald spots suggests alopecia areata, an autoimmune condition with a different treatment pathway entirely. Scalp pain, burning, redness, scaling, or visible scarring points toward scarring alopecias (lichen planopilaris, frontal fibrosing alopecia, central centrifugal cicatricial alopecia), which require prompt diagnosis to halt progression before follicles are permanently destroyed (Kassira et al., 2017, JAAD). Hair loss in women with menstrual irregularities, acne, or excess body hair warrants endocrine evaluation. Rapid progression in a young patient (more than one Norwood stage per year) deserves in-person confirmation and early intervention planning.
The AAD’s position is straightforward: any progressive hair loss that is concerning to the patient is a legitimate reason for dermatology consultation. You don’t need to justify your concern with a clinical threshold.
FAQs
Can stress cause permanent hair loss? Severe stress can trigger telogen effluvium, a temporary diffuse shedding that typically resolves within six to nine months. Stress doesn’t directly cause androgenetic alopecia, but it can unmask or accelerate underlying pattern loss in susceptible individuals.
Is oral minoxidil better than topical? Low-dose oral minoxidil produces comparable effects to topical minoxidil with better adherence for many patients. The choice depends on side-effect tolerance and patient preference and should involve a prescribing clinician.
Is hair loss covered by insurance? Pattern hair loss treatment is generally classified as cosmetic and not covered. Some HSA and FSA accounts cover prescribed medications and physician visits.
How accurate are AI hair-loss assessment tools? AI-based screening tools provide reasonable orientation for self-assessment but do not replace dermatologic evaluation. They work best as a starting point for understanding your likely stage and narrowing treatment options.
Are hair transplants permanent? Transplanted follicles from the genetically resistant donor zone generally retain their DHT resistance and persist long-term. However, surrounding native hair may continue to thin, which is why most patients continue medical therapy after transplantation.
Should I get a hair transplant if I’m in my 20s? Experienced surgeons approach transplantation in patients in their 20s cautiously because the long-term progression pattern isn’t established yet. Medical therapy to stabilize native hair is usually prioritized first.
What’s the best way to photograph hair loss for tracking? Use consistent lighting (natural daylight or a fixed overhead source), the same distance from the camera each time, dry hair in the same style, and shoot front, top, both sides, and back. Set a monthly or quarterly calendar reminder and use the same location in your home.
References
- Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708-728.
- Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365.
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men: short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.
- American Academy of Dermatology Association. Hair loss: diagnosis and treatment. AAD clinical guidance.
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss. J Am Acad Dermatol. 2006;55(6):1014-1023.
- Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109.
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651.
- Gentile P, Garcovich S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil, finasteride, and adult stem cell-based therapy. Int J Mol Sci. 2020;21(8):2702.
- Kassira S, Korta DZ, Chapman LW, Dann F. Frontal fibrosing alopecia: a review. J Am Acad Dermatol. 2017;77(2):209-212.
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786.
Educational content, not medical advice. This article summarizes peer-reviewed sources and clinical guidelines for general informational purposes and does not constitute medical advice, diagnosis, or treatment. Hair loss has multiple possible causes, and an in-person dermatology evaluation is the appropriate starting point for any individual case. Do not start, stop, or change medications based on this article.
Privacy framing for AI-based assessment tools: AI hair-loss screening tools such as Myhairline.ai analyze user-submitted photos using MediaPipe Face Mesh 468-landmark detection. Photos are not stored, and no account is required. The AI output is educational, not diagnostic.
